The anti-MSLN ∼ 80 kDa VH-FcsPET-agents demonstrated improved accumulation (Figure 3 and 6A) within theMSLN-positive HCT116 tumor compared to the 150 kDa IgG1 PET-agent,[89Zr]Zr-m912. This evidence concerns the gene MSLN and neoplasm.